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Abstract 
Background: Myocardial infarction (MI) incidence and mortality display a high geographic variation. Aims: The 
objective of the present study was to analyze MI mortality, cumulative incidence rate variability in seven regions of 
Spain from 1997 to 1998. Methods and Results: Standardized methods were used to identify, find, register, and 
classify MI cases that were classified as definite, possible, insufficient-dataMI, and non-MI. The total population of 
the seven monitored regions was 7,364,682 inhabitants. Of the 11,256 cases fulfilling eligibility criteria to 
investigate, 10,660 were selected to calculate MI rates: 6554 (61.5%)non-fatal definite MI, 1179 (11.1%)fatal definite 
MI, 1859 (17.4%)fatal possible MI, 1068 (10.0%)fatal cases with insufficient data. The IBERICA 25–74 years age-
standardized cumulative incidence rates for men and women, were 207 (range: 175–252) and 45 (range: 36–65) per 
100,000, respectively. The age-standardized mortality rates for men and women, were 73 (range: 62–94) and 20 
(range: 13–29) per 100,000, respectively. Age-standardized case-fatality was 31.4 and 24.2% in men aged 25–74 and 
35–64 years, respectively, and 32.7 and 27.0%, respectively, in women. Conclusions: MI cumulative incidence and 
mortality rates are low compared with other industrialized countries but, vary considerably among regions in a 
Mediterranean country like Spain. 
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Introduction 
Although, coronary heart disease (CHD) mortality rates appear to have decreased and stabilized in the 
last 30 years in Spain [1, 2], CHD is expected to continue to be the leading cause of death in Spain, as in 
other industrialized countries, in the next two decades [3]. However, low event rates are observed in 
Spain as compared with other industrialized countries [4, 5]. 
There are some studies showing a considerable differences of MI event rates among countries [6, 7], 
which arises interesting issues on the determinants of such a variability, taking into account that the low 
incidence rates in southern Europe Mediterranean countries contrasts with the high cardiovascular risk 
factor prevalence observed [8–14]. MI incidence data were scarce in Spain owing to the difficulty of 
recording out-of-hospital fatal MI cases, and the only population data came from two neighboring areas in 
the north-eastern part of the country [4, 5]. 
The objective of the present study was to determine and compare MI event rates in a prospective 
population registry in seven Spanish regions in 1997–1998. 
Methods 
The Investigacion Búsqueda Especı́fica y Registro de Isquemia Coronaria Aguda (IBERICA) study 
was designed to prospectively monitor and compare the MI cumulative incidence and mortality rates and 
28-day case-fatality observed in seven regions of Spain (i.e. Castilla-La Mancha, Gerona, Majorca, 
Murcia, Navarra, Basque Country and Valencia) among residents aged 25–74, in 1997 and 1998. 
Identical methods have been used in all areas to detect MI events, and to record demographic and clinical 
characteristics, and complications including death occurred within 28 days of onset of symptoms. 
Subjects 
The study was designed as a population registry of patients aged 25–74 years with a MI in the seven 
regions of the IBERICA study. The reference population of the participating areas included in average 
3,638,940 men and 3,725,742 women according to official projections for the 1997–1998 period [15]. 
There were 99 hospitals of all levels operating in these areas. 
Case-finding procedures and sources 
Case-finding procedures for hospitalized patients included: (1) A ‘‘hot pursuit’’ during admission was 
used in all hospitals with a reference coronary care or intensive care unit (CCU); (2) to identify patients 
not admitted to a CCU, all medical records of patients with a discharge diagnosis code 410–414 of the 
international classification of diseases 9th revision (ICD-9) were reviewed in all hospitals of the area 
(‘cold pursuit’); (3) the medical records of those patients with the diagnosis ICD-9 410–414 in emergency 
room of all hospitals were also reviewed by cold pursuit; and (4) the records of secondary medically 
attended transportation were also screened to identify possible MI cases referred to medical centers out of 
the area. 
To identify out-of-hospital MI fatal cases all the death certificates containing suggestive ICD-9 410–
414 codes were investigated by reviewing medical records, interviewing physicians who signed the 
selected death certificate or assigned general practitioner, and relatives or witnesses when deemed 
necessary by using a standardized questionnaire. 
Event classification 
Each event was classified according to the MONICA algorithm [16], which takes into account the 
type of symptoms, electrocardiographic (ECG) findings, cardiac enzyme values, and history of ischaemic 
heart disease and necropsy interpretation in fatal cases. Each event was classified into one of the 
following diagnostic categories: 
 
(a) Non-fatal Definite MI patients with serial ECGs showing either: (1) progression from no Q wave to Q 
wave, or (2) ST-segment depression, developing ST segment elevation or progressive T-wave 
inversion, or (3) persistent ST-segment elevation with progressive T-wave inversion, or (4) patients 
with other ECG characteristics and cardiac enzyme levels at least twice the normal limit (creatin-
phosphokinase, and creatin-phosphokinase-MB fraction), either with typical symptoms (chest pain 
lasting at least 20 min which cannot be definitely attributable to non-coronary heart disease 
pathologies) or non-typical symptoms. ECG findings were analyzed by trained medical, but non-
cardiologist, investigators using standardized criteria. 
(b) Fatal Definite MI if they satisfied non-fatal definite criteria or if autopsy showed recent myocardial 
infarction or coronary thrombosis. 
(c) Non-fatal Possible MI events with typical symptoms although without the electrocardiographic or 
enzymatic criteria to be defined as definite MI, but no other definite cause of death. 
(d) Fatal Possible MI involved suggestive terminal symptoms, or a CHD history in the absence of an 
autopsy, or autopsy findings of chronic occlusive CHD or old infarction but no other pathological 
finding suggestive of a fatal disease. 
(e) Fatal Insufficient data events was used when a patient had no record of suggestive symptoms, or 
previous CHD, or an autopsy, and were therefore unclassifiable. 
(f) No myocardial infarction or coronary death when another cause of death was implied by the clinical 
history or at autopsy. Also 28-day cardiac arrest survivors from CHD without criteria to be defined as 
definite or possible, were included in this category. 
 
Rates for fatal and non-fatal definite and fatal possible MI are presented alone and together with 
insufficient-data fatal cases. 
  
Quality control 
All field investigators were trained together in a 2-day course before starting the study. Agreement in 
case classification among them was assessed by a set of cases that had to be independently categorized 
and included some duplicate cases. All investigators had to reach an intraindividual agreement and an 
agreement with the standard classification provided by the coordinating center (i.e. Multiple Kappa 
statistics value ≥ 0.94) to obtain proper accreditation. 
Moreover, all registered events were blindly reclassified into one of the above-mentioned categories in 
the coordinating center, and all discrepancies were discussed with field and local investigators until a 
consensus category was reached. 
The number of the investigated deaths in the study was also compared with the number of coronary 
heart disease deaths in official statistics of each area. The study-to-official rate (i.e. coverage) was 
calculated [17]. Results ranged from 0.95 to 1.23, but all except one had values >1. Data were entered in 
an ad hoc computer program which automatically warned against out-of-range values and checked 
internal consistency of individual information. 
Statistical analysis 
Rates were standardized by age using the world standard population weights for the 25–74 and 35–64 
age intervals [16]: 25–34 (14/50), 35–44 (12/50), 45–54 (11/50), 55–64 (8/50), 65–74 (5/50) in order to 
facilitate comparability with other registers. Case fatality at 28 days was standardized by age for the 35–
64 age interval using the MONICA data center weights: 35–44 (1/11), 45–54 (3/11) and 55–64 (7/11). 
For the 25–74 age interval the following weights were used: 25–34 (1/100); 35–44 (7/100); 45–54 
(16/100); 55–64 (26/100); 65–74 (50/100). 
Aggregated data for 1997–1998 are presented in tables and figures broken down by area, decades of 
age, and sex. Crude and age-standardized cumulative incidence and mortality rates are presented per 
100,000 inhabitants. The study includes 1997–1998 data for all centers excepted Valencia which includes 
only 1998 data. Standardized rates are presented with 95% confidence intervals calculated according to 
the normal approximation of the Poisson distribution. Standardized mortality and cumulative incidence 
ratios with 95% confidence intervals were used to compare each participant region event rate with the 
IBERICA average in the 25–74 years population. 
Results 
Between 1997 and 1998, 11,256 cases fulfilling eligibility criteria were investigated. The distribution by 
diagnostic category and sex is shown in Table 1. Rates were calculated using 10,660 cases (8412 men, 
2248 women) with non-fatal and fatal definite MI, fatal possible MI, and fatal cases with insufficient data. 
The proportion of insufficient data cases in all regions was in average 10.0% of total cases, and 26.0% of 
fatal cases. 
Table 1. Distribution of investigated and included cases by diagnostic categories and sex. Aggregated data from 1997 to 1998 in the 
IBERICA Study (Spain). Age groups 25–74 years 
 Investigated cases  Investigated fatal cases  Included cases 
Diagnostic categories Men N (%) Women N (%)  Men N (%) Women N (%)  Men N (%) Women N (%) 
         
Definite MI  6195 (55.0) 1538 (13.7)  893 (20.6) 286 (6.6)  6195 (58.1) 1538 (14.4) 
Possible MI  1638 (14.6) 463 (4.1)  1454 (33.6) 405 (9.4)  1454 (13.6) 405 (3.8) 
Insufficient data  767 (6.8) 307 (2.7)  763 (17.6) 305 (7.1)  763 (7.2) 305 (2.9) 
Not an MIa 263 (2.3) 85 (0.7)  162 (3.7) 58 (1.3)  — — 
Total  8863 (78.7) 2393 (21.3)  3272 (75.6) 1054 (24.4)  8412 (78.9) 2248 (21.1) 
         
 
MI: Myocardial infarction. 
a After investigating the medical records and interviewing the physician who signed the death certificate and/or the patient relatives 
  
The 1997–1998 crude and age-standardized cumulative incidence and mortality annual rates per 
100,000 inhabitants by age groups, for all definite and fatal possible MI, and with the fatal insufficient 
data category added are presented in Tables 2 and 3, for men and women, respectively. Age-standardized 
cumulative incidence, for the 35–64 and 25–74 years population, were 206 and 207 in men, and 32 and 45 
in women, respectively (Tables 2 and 3). Rates increased smoothly with age in men, while a sharp 
increase appeared in women after the age of 55. Age-adjusted cumulative incidence rates for the 25–74 
years population are presented by sex and region in Figure 1. Two regions had a standardized incidence 
rates significantly over the average, and three regions had rates under the average in men. One was over 
and two under the IBERICA average in women (Figure 1).  
Table 2. Myocardial infarction cumulative incidence and mortality rates per 100,000 men by age and diagnostic categories. 
Aggregated data from 1997 to 1998 in the seven regions of the IBERICA Study (Spain) 
  
NF1+F1+F2 
Annual rate per 100,000 inhabitants 
 
NF1+F1+F2+F9  
Annual rate per 100,000 inhabitants 
Age  Population 
Cumulative incidence 
(N=7649) 
Mortality 
(N=2347) 
 
Cumulative incidence 
(N=8412) 
Mortality 
(N=3110) 
       
25–34  986,992  9 2  9 2 
35–44  851,083  66 14  70 18 
45–54  710,668  201 39  215 53 
55–64  581,897  365 102  398 135 
65–74  508,300  678 264  762 348 
25–74a 3,638,940  210 64  231 85 
25–74b 3,638,940  189 (184–193) 55 (53–57)  207 (202–211) 73 (70–76) 
35–64b 2,143,648  191 (185–197) 46 (43–48)  206 (200–212) 61 (57–64) 
       
 
F1: NF1: Fatal and non-fatal definite myocardial infarction. 
F2: Fatal possible myocardial infarction. 
F9: Fatal insufficient data. 
a Crude rate. 
b Age-standardized rate using world population weights. Rate (95% confidence interval). 
N: Number of cases 
Table 3. Myocardial infarction cumulative incidence and mortality rates per 100,000 women by age and diagnostic categories. 
Aggregated data from 1997 to 1998 in the seven regions of the IBERICA Study (Spain) 
  
NF1+F1+F2 
Annual rate per 100,000 inhabitants 
 
NF1+F1+F2+F9 
Annual rate per 100,000 inhabitants 
Age Population 
Cumulative incidence 
N=1943 
Mortality N=691  
Cumulative incidence N= 
2248 
Mortality N=996 
       
25–34  958,214  1 0  1 0 
35–44  846,396  7 1  8 2 
45–54  709,940  19 4  22 6 
55–64  612,337  74 25  84 35 
65–74  598,855  215 84  251 120 
25–74a 3,725,742  52 19  60 27 
25–74b 3,725,742  39 (38–41) 13 (12–15)  45 (44—47) 20 (18–21) 
35–64b 2,168,673  28 (26–31) 8 (7–9)  32 (30—35) 12 (11–13) 
       
 
F1: NF1: Fatal and non-fatal definite myocardial infarction. 
F2: Fatal possible myocardial infarction. 
F9: Fatal insufficient data. 
a Crude rate. 
b Age-standardized rate using world population weights. Rate (95% confidence interval). 
N: Number of cases 
  
 
 
 
Figure 1. Myocardial infarction age-standardized cumulative incidence annual rate per 100,000 inhabitants in seven regions of 
Spain, 1997–1998, in patients aged 25–74 in the IBERICA Study. Fatal and non-fatal definite, fatal possible and fatal insufficient 
data myocardial infarction cases alone are presented. * Standardized cumulative incidence rate significantly higher than the 
IBERICA average. ** Standardized cumulative incidence ratio significantly lower than the IBERICA average. □□95% Confidence 
interval. 
Age-standardized mortality annual rates per 100,000 inhabitants for the 25–74 years population were 
73 and 20 in men and women, respectively, and are presented by age groups, for all definite and fatal 
possible MI alone, and with the fatal insufficient data category in Tables 2 and 3. Age-standardized 
mortality rates for the 25–74 years population are presented by sex and region in Figure 2. Two regions 
had standardized mortality ratios significantly over the IBERICA average, and four regions had ratios 
under the average in men (Figure 2). These figures were two and one, respectively in women. 
 
 
 
Figure 2. Myocardial infarction age-standardized mortality annual rate per 100,000 inhabitants in seven regions of Spain, 1997–
1998, in patients aged 25–74 in the IBERICA Study. Fatal and non-fatal definite , fatal possible and fatal insufficient data 
myocardial infarction cases alone are presented. * Standardized mortality rate significantly higher than the IBERICA average. ** 
Standardized mortality ratio significantly lower than the IBERICA average. □□ 95% Confidence interval 
  
The number of autopsies was 633 (19.0% of all fatal cases). Crude case-fatality was 30.7% 
(2347/7649) in men aged 25–74 years and 35.6% (691/1943) in women for all definite and fatal possible 
MI. With the fatal insufficient data category added the figures were 37.0 and 41.4%, respectively. Age-
standardized case-fatality was 31.4 and 24.2% in men aged 25–74 and 35–64 years, respectively, and 32.7 
and 27.0%, respectively, in women. These figures increased to 37.7 and 29.7%, and to 44.2 and 35.6%, 
respectively, the fatal insufficient data category was added. 
Discussion 
The present study shows the seven regions of Spain analyzed to be areas with low MI cumulative 
incidence and mortality rates close to those of other southern Europe Mediterranean countries, and much 
lower than the average WHO-MONICA study (see a comparison of selected world regions in Figure 3). 
This fact is noteworthy, since cardiovascular risk factors prevalence in Spain is relatively high [11–14]. 
The possible explanations for this apparent paradox may be related to differing environmental factors (i.e. 
physical activity and antioxidant-rich diet) and their interaction with genetic characteristics of the 
population [10]. Nonetheless, the proportion of mortality due to ischaemic heart disease was 12.1% in 
men (the main individual cause of death) and 10.2% in women (third individual cause of death), in Spain 
in 1997–1998 [1]. Ischaemic heart diseases will have claimed more than 39,000 lives in year 2002 in 
Spain [18]. 
 
 
 
Figure 3. Age-standardized cumulative annual event rate by sex including fatal and non-fatal definite, fatal possible and fatal 
insufficient data myocardial infarction cases in a selection of regions participating in the WHO-MONICA study (aggregated data 
from 1984 to 1995) and in the seven regions of the IBERICA Study, Spain (aggregated data from 1997 to 1998). Based on reference 
number 4 
The large variability in MI event rates within a low MI incidence area indicate that whatever the 
environmental risk (and protective) factors and their interaction with genetic characteristics vary at many 
levels, which provides interesting opportunities for investigating which factors may play a role in 
protecting population from coronary heart diseases. In particular, the effect of high levels of cholesterol 
may not have the same 25-year cardiovascular risk implications in Mediterranean countries of southern 
Europe as in the United States and central or northern Europe [19]. There are data indicating that 
cholesterol levels may have been high for as long as 25 years in Spain without producing the expected 
increase in the number of coronary events [20]. The modulation of cholesterol levels may be sensitive to 
other diet factors such as antioxidants, and to life-style characteristics such as physical activity which are 
frequent in Spain, and may counteract the effect of the high prevalence of cardiovascular risk factors [10]. 
Population 28-day case fatality was higher not only than that described in MI clinical trials (due to 
non-inclusion of patients who die before reaching hospital in the latter), but also than that of hospitalized 
MI patients [15]. Furthermore, our registry showed that 28-day case-fatality increased approximately by 
25% when the 65–74 years decade was considered. Out-of-hospital deaths constitute more than two thirds 
of the 28-day overall case-fatality. 
In our study, the age range was 25–74 years although the usual range in many studies is 35–64 years 
[21]. At least seven MONICA centers widened their registries to cover this range [5, 22, 23]. 
Comparability with other registries is, however, ensured by appropriate standardization of age groups 35–
64 years. 
Study characteristics 
One limitation, shared by all MI registries, arises when a MI patient fails to contact at least one of the 
sources of information periodically checked [10]. This is unlikely to occur [7]. Other limitations of this 
type of registries regard missing silent MI cases and failure to identify MI misdiagnosed as other 
pathologies. The frequency of the former has been estimated to be around 30% of all MI occurred in the 
Framingham cohort [24]. The latter was assessed in an analysis of 395 death certificates investigated in 
one of the participant areas [25]. I was concluded that investigating death certificates with 410–414 ICD 
9th revision codes provided a specific criterion which failed to identify only 0.3% of definite and 3% of 
possible cases as compared with an extended revision of death certificates with other codes (i.e. diabetes 
mellitus, heart failure, hypertensive heart disease, hypertension and arrhythmia). In our study ECG was 
not coded with Minnesota code owing to the complexity of obtaining satisfactory standardization: thus, 
specially trained non-cardiologist physicians assessed ECGs. 
Results have been presented in two groups of MI categories: fatal and non-fatal definite and fatal 
possible, and these categories plus dead patients with insufficient data . Figures obtained by the latter 
represent the most adverse situation if all insufficient data cases were in fact MI patients [25]. Only 3–6% 
of such episodes are given a diagnosis other than MI when evaluated at necropsy [14]. On the other hand, 
the low number of autopsies (19.0% of all fatal cases) led to a greater proportion of possible MI cases. 
Fatal cases classified as insufficient data in the MONICA project represented 22.9% of the whole [4], a 
figure similar to ours (23.6%). The MONICA possible category in the present study was counted when 
assigned to fatal cases only. The 242 cases of non-fatal possible events in our study correspond to a 
clinical diagnosis of non-Q-wave MI or unstable angina cases in whom incomplete or non-specific 
cardiac enzyme curves were found along with a probable or ischaemic ECG. These patients were in 
consequence not included in the analysis. There is a high variability in the proportion of patients with 
non-Q wave MI in clinical series which is likely to be related to the fuzzy limit between non-Q wave MI 
and unstable angina. Neither these, nor other MONICA non-fatal possible cases were included in rate 
calculation since the vast majority of the latter usually correspond to unstable or other forms of angina 
patients and their inclusion would produce a difficult-to-interpret overestimation of rates. In fact, the 
inclusion of this category yields increases in rates that vary greatly among areas [7, 26]. Other more 
sensitive categorization strategies derived from WHO-MONICA algorithm [27] yield higher rates but it is 
likely that specificity then drops owing to inclusion of a number of unstable angina patients as MI. 
Another important characteristic of the study is that we used the classical definition of MI according 
to the MONICA algorithm [16] since the new MI definition was not published at the time the study was 
carried out [28]. 
Conclusion 
Our results confirm that cumulative incidence and mortality rates from MI in Spain are among the 
lowest in the industrialized world, although there is a substantial variability in event rates among regions 
in Spain: regions with the highest rates have approximately 50% higher rates than the regions with the 
lowest rates. 
  
Key messages 
• The myocardial infarction rates in Spain are among the lowest of the industrialized world, 
• there is a substantial variability in event rates among regions, 
• the variability among Spanish regions is lower than that found in international comparisons. 
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from Villar L, Constela D, Garcı́a A, Piñera P, Llamas C, Calvo AM y Aragón A, Marco R. They also 
grateful to Christine O’Hara for the English revision. 
Appendix 1 
IBERICA Study Investigators: 
IBERICA-Basque Country: Elena Aldasoro (PI); Eva Alonso; Fernando Arós; José Ma Arteagoitia 
(PI); Covadonga Audicana; Mikel Basterretxea; Eduardo Castillo (†) Santiago Esnaola; Miguel A Garcı́a 
Calabuig; Iraida Hurtado de Saracho; Miren Josebe Laresgoiti; Nerea Larrañaga; Marı́a José Lasa; Iñaki 
Lecuona; Nerea Muniozguren; Ma CresTobalina; JesúsMa San Vicente; Emilio Sanz. 
IBERICA-Murcia: Lluı́s Cirera; JoséGarcı́a; Carmen Navarro; Ma José Tormo (PI); Consuelo 
Martı́nez; Josefa Contreras; Fuensanta Aliaga; José Ma Alonso; Manuel Belda; Rafael Bañón; 
JoséAntonio Castaño; Antonio Castilla; Juan Manuel Chiner; José Ma Clemente; Amparo Egea; Francisco 
Felices; Manuel Fuentes; José Galcerá; Arcadio Garcı́a; Francisco Garcı́a; Pedro Garcı́a; Gurmesindo 
González; Faustino Herrero; Pedro Jara; José Antonio Melgarejo; José Muñoz; Silvestre Nicolás; Juan 
Ortega; Miguel de Paco; Emilio Pérez; Pascual Rodrı́guez; Francisco Javier Rodrı́guez; Julio Ródenas; 
Francisco Ruiz-Martı́nez; José Antonio Ruiz; Fernando de San Eustaquio; Josefa Segura; José Antonio 
Serrano; Gines Torres; Luis Carlos Torres; Juan Vidal; Manuel Villegas. 
IBERICA-Valencia: Amparo Albiñana; Carlos Antón; Joaquı́n Arguedas; Santiago Borrás; Susana 
Bosch; Adolfo Cabadés (PI); José P Calabuig; Enrique Castellanos; Javier Cebrián; Francisco J Domingo; 
Ildefonso Echánove; Enrique Ferrer; Mercedes Francés; Eva Gómez; Julián González; José Gregori; 
Javier Haba; Antonio López; Vicente López; Inmaculada Melchor; Rafael Montero; Julio Montes; Ramón 
Navarro; Manuel Palanca; Miguel Palencia; Miguel Pérez; Paula Ramı́rez; Juan Antonio Rodrı́guez; 
Manuel Roig; Javier Ruiz; Antonio Salvador; José Sotillo; Francisco Valls; Hermelinda Vanaclocha (PI); 
José Antonio Velasco; Oscar Zurriaga. 
IBERICA-Castilla-La Mancha: Centro Coordinador: Antonio Segura (PI); Gema Vega (PI); Gema 
Rius. Investigadores colaboradores: Enrique Almar; Miguel Artigao; Esther Bermejo; Carmen Garcı́a; 
Francisco Garcı́a; Pedro Antonio Jiménez; Javier Lucas; Antonio Mateos; Amalia Navarro; Angel Puras; 
José Marı́a Garcı́a. 
IBERICA-Majorca: José Ingacio Ayestarán; Jaime Bergadá; Armando Bethencourt; Silvia Carretero; 
Magdalena Esteva; Miguel Fiol (PI); Catalina Forteza; José Francisco Forteza; Pedro Ibáñez; Josu López; 
Antonio Nicolau; Jon Pérez; Marı́a Riera; Antonio Rodrı́guez; Ana Rotger; Catalina Rubert; Joan Soler; 
Enrique Sospedra; Francisca Vara; Bernardo Vidal. 
IBERICA-Navarra: Eduardo Alegrı́a; Raquel Ancin; Enrique los Arcos; José Ramón Carmona; Vega 
Garcı́a (PI); Conchi Moreno (PI); Teresa Rubio; Rafael Tejeira; Eugenio Torrano; Javier Turumbay. 
IBERICA-Gerona: Antoni Agustı́; Xavier Albert; Mariona Barcons; Francina Bassó; Josep Bisbe; 
Mariona Cardona; Núria Constans; Pere Cortés; Ma Isabel Covas; Roberto Elosua; Miguel Gil; Josep 
Carles Guerra; Rafel Masiá; Jaume Marrugat (PI); Silvia Martı́n; Carles Martı́nez; Angels Masabeu; Ma 
Rita Massa; Francisco Monzón; Araceli Pena; Gloria Pérez; Carles Ponsatı́; Isabel Ramió; Pere Roset; 
Izabella Rohlfs; Júlia Roura; Montserrat Sagué; Joan Sala (PI); Mariano Sentı́; Joan Vila. 
IBERICA-A Coruña: Antonio Amaro; Eugenia Ameneiros; Sara Cerdeira; Teresa Eguileta (†) Jorge 
Hervada; Alejandro Mesı́as; Javier Muñiz (PI); Pedro Rigueiro; Enrique Sáez; Jorge Salgado; Nicolás 
Vázquez; Luciano Vidán Martı́nez. 
IBERICA- Coordinating centre: Jaume Marrugat; Roberto Elosua. 
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